CUPERTINO, Calif., Sept. 15 /PRNewswire-FirstCall/ -- DURECT Corporation
(Nasdaq: DRRX) announced today that it will present at the 2008 UBS Global
Life Sciences...
CUPERTINO, Calif., Nov. 20 /PRNewswire-FirstCall/ -- via COMTEX -- DURECT Corporation (Nasdaq: DRRX) announced today that it will present a corporate overview and update at the 19th...
DURECT Corporation (Nasdaq: DRRX Message Board Stocks) announced today that Voyager Pharmaceutical has provided its shareholders with an update on its truncated Phase 3 clinical trial for Memryte,...